Publication | Closed Access

Costs of Trastuzumab in Combination With Chemotherapy for HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: An Economic Evaluation in the Chinese Context

OncologyEsophageal CancerHealth EconomicsGastrointestinal OncologyGastroenterologyHer2-positive Advanced GastricSurgeryCost EffectivenessCancer TreatmentEconomic EvaluationMedicineRadiation OncologyCancer ResearchChinese ContextHealth Sciences